BioMed X, an innovation hub for pharma with headquarters in Heidelberg, has appointed Nico Frisch as Vice President, Site Head Heidelberg.

In his new role, Frisch will be responsible for administrative strategy, operational excellence, and institutional governance at the Heidelberg site, supporting BioMed X’s mission to accelerate innovative biomedical research at the interface of academia and industry.

Experience

Frisch is an administration and operations professional with hands-on experience in academic and research-driven environments. From 2022 to 2025, he served as Head of Administration at the Max Planck Institute for Medical Research in Heidelberg, where he was directly responsible for administrative operations, budgeting, and procurement. In this role, he worked closely with scientific leadership to ensure efficient, compliant, and future-oriented institutional operations.

He holds a Bachelor of Arts in Business Administration from DHBW Mosbach, Germany (2019) and a Master of Arts from IU International University (2022). Frisch is currently pursuing a PhD in Organization and Management of Information Processes related to Economics at UNIBIT in Sofia, Bulgaria, in a remote program, in which he analyses the impact of government funded R&D of economic growth.

“One of my key priorities in 2026 will be the planned move into our new facilities in Heidelberg,” Frisch said. “This relocation is the central operational project of the year and a decisive step in creating a centralized infrastructure that supports the scale, complexity, and interdisciplinary nature of our research moving forward. My focus is on ensuring a smooth transition and establishing an environment that enables our teams to collaborate efficiently and work with a long-term perspective.”

More BioMed X News

BioMed X recently partnered with the government of Barbados on research for AI-enabled therapy. Specifically, early diabetic kidney disease is this project’s focus.